Patents
Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
04/1999
04/14/1999EP0819119A4 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
04/08/1999WO1999005521A3 Conjugate for differentiating between healthy and unhealthy tissue
04/08/1999WO1999003823A3 Novel polyamine analogues as therapeutic and diagnostic agents
04/06/1999US5892042 Acridine derivative metal complexes used for transparent recording medium or optical recording medium
03/1999
03/30/1999US5888498 Cellular and animal models for diseases associated with mitochondrial defects
03/25/1999WO1999014220A1 Novel compounds for generating chemiluminescence with a peroxidase
03/23/1999US5886185 Polyamine-linked acridine dimers
03/23/1999US5886007 THA analogs useful as cholinesterase inhibitors
03/10/1999CN1042421C Preparation of acridine derivatives
03/09/1999US5879894 Detection and/or quantitation of at least two substances in a test sample; application in clinical diagnostics
03/04/1999WO1998054148A3 Quinoline and acridine derivatives as antiarrhythmic agents
02/1999
02/25/1999WO1999009012A1 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein
02/18/1999WO1999007683A1 Method for producing 3,6-diaminoacridine or its monohydrochloride
02/11/1999WO1999006372A1 Bis-acridinecarboxamides having antitumor activity
02/04/1999WO1999005521A2 Conjugate for differentiating between healthy and unhealthy tissue
02/03/1999EP0894261A1 Covalently immobilized fluoroionophores as optical ion sensors
02/02/1999US5866335 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions
01/1999
01/28/1999WO1999003823A2 Novel polyamine analogues as therapeutic and diagnostic agents
01/28/1999DE19731741A1 Konjugat zur Unterscheidung von krankhaftem und gesundem Gewebe Conjugate to distinguish between diseased and healthy tissue
01/28/1999CA2297413A1 Novel polyamine analogues as therapeutic and diagnostic agents
01/27/1999EP0892801A1 Acridone-derived compounds useful as antineoplastic and antiretroviral agents
01/27/1999EP0778947A4 Chemiluminescent detection of hydrolytic enzymes using an acridan
01/27/1999EP0778946A4 Novel method and kits for producing light from an acridan compound
01/19/1999US5861411 Treating disturbances of memory such as senile dementia and alzheimer's disease
01/13/1999EP0890176A1 Proton conductor in liquid form
01/13/1999EP0889863A2 Surface modified carbonate materials
01/07/1999EP0888290A1 Azulenyl nitrone spin trapping agents, methods of making and using same
12/1998
12/29/1998US5854274 Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives
12/23/1998WO1998057956A1 Bis(9-aminoacridine) dna intercalating agents having antitumor a activity
12/23/1998EP0471792B1 Methods, reagents and test kits for determination of subpopulations of biological entities
12/17/1998WO1998056765A1 Heterocyclic chemoluminescent derivatives
12/08/1998US5846969 Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives
12/08/1998CA2006074C Photopolymerizable mixture and photopolymerizable copying material containing same
12/03/1998WO1998054148A2 Quinoline and acridine derivatives as antiarrhythmic agents
12/01/1998US5844024 Cyclic diphenylacetonitriles as stabilizers
12/01/1998US5843666 Chemiluminescent detection methods using dual enzyer-labeled binding partners
11/1998
11/24/1998US5840873 Plurality of different oligonucleotide probes each coupled to different chemiluminescent label
11/24/1998US5840493 Diagnosis of late onset diabetes by detection of mutations in adenosine triphosphate synthase or transfer rna (lys) genes in a biological sample; labelled nucleotide sequences as detectors; accuracy
11/18/1998EP0877735A1 Polycyclic compounds
11/18/1998CN1199046A Process for preparing 2-anilinoacridones
11/11/1998EP0877021A1 Process for preparing 2-anilinoacridones
11/11/1998EP0877020A1 Acridone derivative
11/11/1998EP0876363A1 Polymer-bound fluorophores as optical ion sensors
11/10/1998US5834462 Antitumor agents; anticarcinogenic agents particularly for nasopharyngel, pulmonary, intestinal, mammary, uterus, gastric, ovarian or liver cancer and also leukemia
11/10/1998US5834157 Photoinitiators; reduced diffusion and sublimation
11/09/1998CA2237077A1 Process for preparing 2-anilinoacridones
11/05/1998WO1998049146A2 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
11/05/1998CA2288154A1 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
11/03/1998US5830834 Ammonium carboxylate type fluorine-containing compound, solid surface modifier containing the same and magnetic recording medium using the same
10/1998
10/27/1998US5827656 Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences
10/08/1998WO1998029358A3 Surface modified carbonate materials
10/07/1998EP0869109A1 Process for the production of 9-anthraldehydes
10/06/1998US5817684 Administering an aromatic alcohol compound
10/01/1998WO1998042655A1 Spiro compounds and the use thereof
10/01/1998DE19711714A1 Spiroverbindungen und deren Verwendung Spiro compounds and their use
09/1998
09/23/1998EP0866110A1 Light-emitting material for organo-electroluminescence device and organic electroluminescence device
09/15/1998US5808077 Intercalators having affinity for DNA and methods of use
08/1998
08/27/1998WO1998007844A3 Screening assay for the identification of agents which alter expression of pth-rp
08/12/1998EP0857721A1 Acridone compounds
08/11/1998US5792863 Having large absorption in near infrared, reduced absorption in visible range
08/04/1998US5789139 Storage stability
07/1998
07/21/1998US5783699 Chemiluminescent acridinium salts
07/21/1998US5783584 THA analogs useful as cholinesterase inhibitors
07/16/1998WO1998030545A1 Frangible compounds for pathogen inactivation
07/16/1998WO1998030544A1 9,10-dihydroacridine derivatives possessing antimicrobial activity
07/16/1998WO1998030327A1 Methods and devices for the reduction of small organic compounds from blood products
07/16/1998WO1998030218A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents
07/16/1998CA2276525A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents
07/09/1998WO1998029877A1 Proton conductor in liquid form
07/09/1998WO1998029399A1 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
07/09/1998WO1998029396A1 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
07/09/1998WO1998029389A1 Malononitrile-derivative anion salts, and their uses as ionic conducting materials
07/09/1998WO1998029388A1 Perfluorinated amide salts and their uses as ionic conducting materials
07/09/1998WO1998029358A2 Surface modified carbonate materials
07/09/1998CA2805188A1 Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye
07/09/1998CA2704986A1 Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye
07/09/1998CA2683826A1 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
07/01/1998EP0850933A1 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials
07/01/1998EP0850932A1 Salts of heterocyclic anions and their uses as ionic conductive materials
07/01/1998EP0850921A1 Salts of malononitrile derived anions, and their uses as ionic conductive materials
07/01/1998EP0850920A2 Salts of perfluorinated amides and their uses as ionic conductive materials
07/01/1998EP0850224A1 Radiation-activated cytotoxin therapy
06/1998
06/30/1998US5773592 Pro drugs for selective drug delivery
06/25/1998WO1998027101A1 Novel catalysts made from transition metal compounds and 4,5-diphosphinoacridine-ligands
06/25/1998CA2275309A1 Novel catalysts made from transition metal compounds and 4,5-diphosphinoacridine-ligands
06/18/1998WO1998025616A1 Leukotriene antagonists for cerebral focal stroke
06/18/1998WO1998025615A1 Leukotriene antagonists for oral squamous cell carcinoma
06/18/1998DE19652350A1 Neue Katalysatoren aus Übergangsmetallverbindungen und 4,5-Diphosphinoacridin-Liganden New catalysts consisting of transition metal compounds and 4,5-Diphosphinoacridin ligands
06/18/1998CA2274908A1 Leukotriene antagonists for cerebral focal stroke
06/18/1998CA2274855A1 Leukotriene antagonists for oral squamous cell carcinoma
06/16/1998US5767126 Alzheimer's disease treatment with tacrine metabolites
06/04/1998WO1998023589A1 Process for converting hydroxy heteroaromatics to arylamines
06/02/1998US5760205 Isolated nucleotide sequences corresponding to mitochondrial cytochrome oxidase genes
05/1998
05/26/1998US5756709 Compositions for the simultaneous detection and quantification of multiple specific nucleic acid sequences
05/22/1998WO1998021586A1 Chemiluminescent detection methods using dual enzyme-labeled binding partners
05/22/1998CA2259963A1 Chemiluminescent detection methods using dual enzyme-labeled binding partners
05/12/1998US5750698 Aryl N-alkylacridancarboxylate derivatives useful for chemiluminescent detection
04/1998
04/30/1998WO1998017826A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus
04/30/1998WO1998017650A1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
04/30/1998WO1998017649A1 Process for the preparation of n-[2-(dimethylamino)ethyl]acridine-4-carboxamide
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22